
### [NCIT:C6422](http://purl.obolibrary.org/obo/NCIT_C6422)
**Label:** Midgut Carcinoid Tumor

**Subclasses:** [NCIT:C40014](http://purl.obolibrary.org/obo/NCIT_C40014) (Ovarian Trabecular Carcinoid Tumor), [NCIT:C5229](http://purl.obolibrary.org/obo/NCIT_C5229) (Ovarian Carcinoid Tumor), [NCIT:C40015](http://purl.obolibrary.org/obo/NCIT_C40015) (Ovarian Mucinous Carcinoid Tumor), [NCIT:C6427](http://purl.obolibrary.org/obo/NCIT_C6427) (Ascending Colon Neuroendocrine Tumor G1), [NCIT:C6424](http://purl.obolibrary.org/obo/NCIT_C6424) (Meckel Diverticulum Neuroendocrine Tumor G1), [NCIT:C5501](http://purl.obolibrary.org/obo/NCIT_C5501) (Cecum Neuroendocrine Tumor G1), 

**Class expressions from DL-Learner:**

- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C36855](http://purl.obolibrary.org/obo/NCIT_C36855) (Malignant Neuroendocrine Polygonal Cell))) 54.17%
- Thing 52.77%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 39.52%


